Abeona Therapeutics (ABEO) Other Accumulated Expenses (2021 - 2025)

Abeona Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $2000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 96.88% year-over-year to $2000.0; the TTM figure through Dec 2025 stood at $2000.0 (down 96.88% YoY), while the FY2025 annual figure was $2000.0, down 96.88% from the prior year.
• Other Accumulated Expenses was $2000.0 for Q4 2025 at Abeona Therapeutics, down from $35000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $317000.0 in Q1 2025 to a low of $1000.0 in Q4 2023.
• Historically, Other Accumulated Expenses has averaged $115071.4 across 5 years, with a median of $72000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses tumbled 99.51% in 2024, then surged 31600.0% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $296000.0 in 2021, then tumbled by 31.08% to $204000.0 in 2022, then tumbled by 99.51% to $1000.0 in 2023, then surged by 6300.0% to $64000.0 in 2024, then tumbled by 96.88% to $2000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $2000.0 (Q4 2025), $35000.0 (Q3 2025), and $80000.0 (Q2 2025), per Business Quant data.